Bank of New York Mellon’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Sell
59,225
-1,982
-3% -$44K ﹤0.01% 2953
2025
Q1
$1.14M Buy
61,207
+4,038
+7% +$75.1K ﹤0.01% 2978
2024
Q4
$757K Sell
57,169
-1,972
-3% -$26.1K ﹤0.01% 3290
2024
Q3
$1.98M Sell
59,141
-15,369
-21% -$515K ﹤0.01% 2742
2024
Q2
$1.87M Buy
74,510
+10,423
+16% +$261K ﹤0.01% 2826
2024
Q1
$1.44M Sell
64,087
-5,949
-8% -$134K ﹤0.01% 2947
2023
Q4
$1.5M Buy
70,036
+631
+0.9% +$13.5K ﹤0.01% 2965
2023
Q3
$1.25M Buy
69,405
+24
+0% +$431 ﹤0.01% 3044
2023
Q2
$1.41M Sell
69,381
-6,623
-9% -$135K ﹤0.01% 3017
2023
Q1
$1.65M Sell
76,004
-1,043
-1% -$22.7K ﹤0.01% 2903
2022
Q4
$2.39M Sell
77,047
-7,057
-8% -$219K ﹤0.01% 2755
2022
Q3
$2.15M Buy
84,104
+6,862
+9% +$175K ﹤0.01% 2801
2022
Q2
$1.57M Sell
77,242
-7,473
-9% -$152K ﹤0.01% 2967
2022
Q1
$2.1M Sell
84,715
-865
-1% -$21.4K ﹤0.01% 2908
2021
Q4
$2.97M Buy
85,580
+3,544
+4% +$123K ﹤0.01% 2750
2021
Q3
$2.23M Buy
82,036
+3,185
+4% +$86.4K ﹤0.01% 2924
2021
Q2
$2.05M Sell
78,851
-21,578
-21% -$560K ﹤0.01% 2966
2021
Q1
$2.16M Buy
100,429
+343
+0.3% +$7.39K ﹤0.01% 2883
2020
Q4
$2.15M Sell
100,086
-5,644
-5% -$121K ﹤0.01% 2801
2020
Q3
$1.56M Sell
105,730
-2,596
-2% -$38.3K ﹤0.01% 2816
2020
Q2
$2.42M Buy
108,326
+3,661
+3% +$81.8K ﹤0.01% 2568
2020
Q1
$1.48M Buy
104,665
+4,270
+4% +$60.3K ﹤0.01% 2710
2019
Q4
$1.63M Buy
100,395
+812
+0.8% +$13.2K ﹤0.01% 2945
2019
Q3
$3.49M Sell
99,583
-422
-0.4% -$14.8K ﹤0.01% 2455
2019
Q2
$5.64M Buy
100,005
+12,305
+14% +$694K ﹤0.01% 2271
2019
Q1
$6.41M Buy
87,700
+2,170
+3% +$159K ﹤0.01% 2212
2018
Q4
$5.46M Sell
85,530
-3,317
-4% -$212K ﹤0.01% 2235
2018
Q3
$8.86M Buy
88,847
+4,900
+6% +$489K ﹤0.01% 2090
2018
Q2
$5.96M Buy
83,947
+6,355
+8% +$451K ﹤0.01% 2305
2018
Q1
$8.08M Sell
77,592
-14,838
-16% -$1.54M ﹤0.01% 2100
2017
Q4
$9.31M Buy
92,430
+54,189
+142% +$5.46M ﹤0.01% 2026
2017
Q3
$1.34M Buy
38,241
+18,497
+94% +$647K ﹤0.01% 3062
2017
Q2
$473K Buy
19,744
+6,297
+47% +$151K ﹤0.01% 3626
2017
Q1
$373K Buy
+13,447
New +$373K ﹤0.01% 3671